ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000

November 10, 1989

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

Charles Blanke Named Chair-Elect of SWOG

April 20, 2012

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980